Cite
HARVARD Citation
Golob, S. et al. (2022). Letermovir for cytomegalovirus prophylaxis in high‐risk heart transplant recipients. Clinical transplantation. 36 (12), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Golob, S. et al. (2022). Letermovir for cytomegalovirus prophylaxis in high‐risk heart transplant recipients. Clinical transplantation. 36 (12), p. n/a. [Online].